Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
ACLX
ACLX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ACLX News
Arcellx's Novel D-Domain Binder Accepted for Presentation at 2026 Tandem Meetings
Feb 04 2026
Newsfilter
Director David Lubner Sells 6,000 Shares of Arcellx Stock
Feb 01 2026
Fool
FDA Draft Guidance Boosts Arcellx (ACLX) and Legend Biotech (LEGN) Stock Prices
Jan 20 2026
seekingalpha
Stocks to Consider Buying in 2026: Insights from Our Roundtable Experts, Including DoorDash and LVMH
Jan 16 2026
Barron's
Wells Fargo Upgrades Arcellx to Overweight Due to Potential of Multiple Myeloma CAR-T Asset
Dec 22 2025
SeekingAlpha
Deutsche Bank Raises Woodward Price Target to $400, Reiterates Buy
Dec 22 2025
CNBC
Cancer Research Boosts Confidence in These Small Biotech Companies
Dec 09 2025
Barron's
What’s Driving the Surge in Arcellx Stock Today?
Dec 08 2025
Benzinga
Major Stocks on the Rise Monday: Paramount Skydance, Wave Life Sciences, Ocular Therapeutix, Carvana, and More
Dec 08 2025
Benzinga
Market Update: Health Care Stocks Gain Ahead of Monday's Opening Bell
Dec 08 2025
Yahoo Finance
Arcellx Reports 96% Overall Response Rate in Phase 2 Study of Anitocabtagene Autoleucel for Multiple Myeloma
Dec 06 2025
Businesswire
Arcellx Plummets After Kelonia CAR-T Therapy Results for Multiple Myeloma Are Released
Nov 24 2025
SeekingAlpha
Options Trading for Arcellx (ACLX) in the First Week of January 2026
Nov 24 2025
NASDAQ.COM
Stifel Reaffirms Buy Rating for Arcellx with $129 Price Target
Oct 16 2025
Benzinga
Essay | Experiencing a Rare One-in-a-Million Cancer Diagnosis
Sep 19 2025
WSJ
Breaking Down the Numbers: EZM on Track for $74
Sep 18 2025
NASDAQ.COM
Show More News
